Court Constructs Claims in Illumina vs. Affymetrix IP Suit; Trial Date Moved to 2011 | GenomeWeb

By Justin Petrone

An ongoing IP dispute between array vendors Illumina and Affymetrix inched closer to resolution last week, as a US District Court ruled on the meanings of patent claims central to the case.

Judge Barbara Crabb of the US District Court for the Western District of Wisconsin handed down her claims construction ruling July 14, tacking closer to defendant Affymetrix's proposed definitions of certain claims, without full adoption of Affy's proposed language.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.